Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose Ranging Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism

NCT00004699 is registered in ClinicalTrials.gov with Children's Hospital of Philadelphia as lead sponsor.

NCT NCT00004699
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00004699 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose Ranging Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism
Lead sponsor
Children's Hospital of Philadelphia
Phase
Not applicable
Overall status
Completed
Start date
August 31, 1995
Completion date
January 31, 1999
Enrollment
8
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hyperinsulinism